LGND

Ligand Pharmaceuticals Incorporated

Price

$299.00

return (12m)

57.05%

p/e

32.49

p/bv

6.62

DIVIDEND YIELD

0.00%

LGND price

Ligand Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

today you would have:

*The amount considers the reinvestment of dividends.

Return on Investment LGND

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-0.10%

3 months

3.41%

1 year

57.05%

2 years

169.05%

5 years

94.47%

10 years

208.83%

Profitability Comparator

If you had invested

years ago

today you would have:

Fundamentals LGND

Valuation

P/E

32.49

Sector -3.16

Industry -3.16

P/BV

6.62

Sector 1.80

Industry 1.80

P/Revenue (PSR)

22.05

Sector 2.05

Industry 2.05

EV/EBITDA

18.14

Sector -210.13

Industry -210.13

EV/EBIT

20.68

Sector -36.38

Industry -36.38

P/EBITDA

23.01

Sector -19.73

Industry -19.73

P/EBIT

26.24

Sector -67.09

Industry -67.09

P/Total Assets

2.93

Sector 1.06

Industry 1.06

P/Net Current Assets

26.84

Sector -9.56

Industry -9.56

P/Working Capital

4.54

Sector -93.54

Industry -93.54

EPS

9.83

Sector -1.78

Industry -1.78

BVPS

48.22

Sector 1.99

Industry 1.99

Efficiency

Gross Margin

100.00%

Sector 41.27%

Industry 41.27%

EBITDA Margin

117.36%

Sector -21,198.78%

Industry -21,198.78%

EBIT Margin

32.61%

Sector -35.28%

Industry -35.28%

Net Profit Margins

67.88%

Sector -35.71%

Industry -35.71%

Asset Turnover

0.03

Sector 0.03

Industry 0.03

Profitability

ROE

21.96%

Sector -61.33%

Industry -61.33%

ROA

12.58%

Sector -54.29%

Industry -54.29%

ROIC

3.43%

Sector -1,801.33%

Industry -1,801.33%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

31.18

Sector 2.91

Industry 2.91

Net Debt / EBITDA

-4.88

Sector -20.88

Industry -20.88

Net Debt / EBIT

-5.56

Sector -3.40

Industry -3.40

Net Debt / Equity

-1.40

Sector -34,305.41

Industry -34,305.41

Gross Debt / Equity

0.00

Sector -0.81

Industry -0.81

Equity/Assets

0.44

Sector 0.46

Industry 0.46

Liabilities/Assets

0.56

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

3.76%

Sector -

Industry -

5Y Earnings CAGR

28.12%

Sector -

Industry -

Fundamentals LGND

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Ligand Pharmaceuticals ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$299.00

Fair Value

$103.27

Upside

-65.46%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
LGND Ligand Pharmaceuticals Incorporated	$299.00	57.83%	0.00%	32.49	6.62	21.96%	67.88%
PFE Pfizer Inc.	$29.88	31.85%	5.59%	43.90	1.99	4.43%	6.34%
ABBV AbbVie Inc.	$288.24	37.21%	2.31%	53.66	0.00	-%	14.76%
NVO Novo Nordisk A/S	$40.30	-9.03%	4.66%	9.73	5.17	60.28%	35.32%
MRK Merck & Co. Inc.	$146.94	80.36%	2.26%	151.28	8.26	5.07%	3.64%
AZN AstraZeneca PLC	$186.85	13.45%	1.71%	25.01	5.71	24.18%	18.97%
BMY Bristol-Myers Squibb Company	$63.13	44.63%	5.06%	13.78	5.44	44.06%	18.47%
ZTS Zoetis Inc.	$82.11	-32.76%	2.60%	12.71	10.64	64.91%	27.69%
AMGN Amgen Inc.	$460.28	60.27%	2.13%	28.86	21.58	91.47%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$902.90	40.13%	0.41%	21.68	2.96	14.04%	27.86%
HALO Halozyme Therapeutics Inc.	$122.96	80.69%	0.00%	37.10	106.90	173.67%	24.86%
MCK McKesson Corporation	$1,072.00	27.98%	0.34%	25.96	-30.85	-168.45%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$542.50	28.66%	0.00%	32.22	7.01	23.54%	35.00%
CAH Cardinal Health Inc.	$267.82	38.41%	0.81%	34.74	-21.86	-63.98%	0.67%
ARGX argenx SE	$894.77	7.61%	0.00%	13.26	-	-%	25.42%
HRMY Harmony Biosciences Holdings Inc.	$32.47	5.70%	0.00%	12.39	2.25	20.46%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

today you would have:

*This calculation reflects price variation only.

LGND - Historical Dividends

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	04/03/2007	04/19/2007	15.00000000

ABOUT Ligand Pharmaceuticals

Ligand Pharmaceuticals Incorporated

Average Investor10 user rating

4.0 (0 people)

United States

39 years

Founded: 1987

1995

Time since IPO - 31 years

115

Employees

Ligand Pharmaceuticals Incorporated (United States) is listed on the Nasdaq and has a market capitalization of $6.41 billion, with shareholders equity totaling $967.52 million.

The company employs approximately 115 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Ligand Pharmaceuticals Incorporated reported $290.54 million in revenue, generating net income of $197.22 million.

Key financial metrics include a P/E ratio of 32.49, a price-to-book (P/B) ratio of 6.62, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker LGND.

Market cap

$6.41 billion

Net worth

$967.52 million

$967,516,000.00

Assets

$2.19 billion

$2,185,875,000.00

Total Shares Outstanding

20.06 million

20,063,000

Average Daily Trading Volume

$236.12 Thousand

$236,120.00

Sector

Health Care

Industry

Biotechnology

LGND

LGND revenue and profits

Financial Results LGND

DRAG THE FRAME TO SEE MORE DATA

LGND cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$1,072.00 25,46% (12M)

P/E

25.96

0.34%

ROE

-168.45%

P/BV

-30.85

CAH - Cardinal Health

$267.82 36,55% (12M)

P/E

34.74

0.81%

ROE

-63.98%

P/BV

-21.86

MRK - Merck & Co.

$146.94 76,32% (12M)

P/E

151.28

2.26%

ROE

5.07%

P/BV

8.26

ABBV - AbbVie

$288.24 35,79% (12M)

P/E

53.66

2.31%

ROE

P/BV

0.00

PFE - Pfizer

$29.88 30,58% (12M)

P/E

43.90

5.59%

ROE

4.43%

P/BV

1.99

AZN - AstraZeneca

$186.85 12,36% (12M)

P/E

25.01

1.71%

ROE

24.18%

P/BV

5.71

BMY - Bristol-Myers Squibb

$63.13 41,40% (12M)

P/E

13.78

5.06%

ROE

44.06%

P/BV

5.44

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$1,072.00 25,46% (12 M)

P/L

25.96

0.34%

ROE

-168.45%

P/VP

-30.85

CAH - Cardinal Health

$267.82 36,55% (12 M)

P/L

34.74

0.81%

ROE

-63.98%

P/VP

-21.86

MRK - Merck & Co.

$146.94 76,32% (12 M)

P/L

151.28

2.26%

ROE

5.07%

P/VP

8.26

ABBV - AbbVie

$288.24 35,79% (12 M)

P/L

53.66

2.31%

ROE

P/VP

0.00

PFE - Pfizer

$29.88 30,58% (12 M)

P/L

43.90

5.59%

ROE

4.43%

P/VP

1.99

AZN - AstraZeneca

$186.85 12,36% (12 M)

P/L

25.01

1.71%

ROE

24.18%

P/VP

5.71

BMY - Bristol-Myers Squibb

$63.13 41,40% (12 M)

P/L

13.78

5.06%

ROE

44.06%

P/VP

5.44

Frequently Asked Questions

What is the price of Ligand Pharmaceuticals (LGND) today?

The current price of Ligand Pharmaceuticals (LGND) is $299.00. The stock began the year trading around $189.07 and is currently priced at $299.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Ligand Pharmaceuticals (LGND) pay dividends?

Ligand Pharmaceuticals (LGND) did not pay dividends over the past year.

Is Ligand Pharmaceuticals (LGND) a good investment?

Ligand Pharmaceuticals (LGND) is currently trading at $299.00 with a P/E ratio of 32.49. This represents a -8,901% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 57.05%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Ligand Pharmaceuticals (LGND) stock?

You can buy Ligand Pharmaceuticals (LGND) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol LGND and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Ligand Pharmaceuticals (LGND) yield today?

Over the past month, Ligand Pharmaceuticals (LGND) has returned -0.10% — 57.05% over the past year, and 94.47% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Ligand Pharmaceuticals (LGND) today at the current price of $299.00 your total investment would be $29,900.00.

Based on historical performance, the investment would have grown to approximately:

$46,957.95 after 1 year
$58,146.53 after 5 years
$92,340.17 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

LGND

Ligand Pharmaceuticals Incorporated

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment LGND

Target price created!

Delete target price?

Your Target Price strategy deserves unlimited alerts

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING LGND WITH OTHER STOCKS

type

Ex - Dividend Date

payment date

value

ABOUT Ligand Pharmaceuticals

Ligand Pharmaceuticals Incorporated

United States

39 years

1995

115

PROFIT X PRICE LGND

Financial Results LGND

LGND cash flow

Asset, Revenue and Profit Growth - LGND

LGND balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

BMY - Bristol-Myers Squibb

Frequently Asked Questions